down arrow

Cosmos Health, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2214133058
USD
0.41
0.05 (14.79%)

Sep 23

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Palatin Technologies, Inc.
Cosmos Health, Inc.
Protara Therapeutics, Inc.
Entera Bio Ltd.
Acasti Pharma, Inc.
Cocrystal Pharma, Inc.
AIM ImmunoTech, Inc.
Alzamend Neuro, Inc.
Vincerx Pharma, Inc.
TFF Pharmaceuticals, Inc.
Acer Therapeutics, Inc.

Why is Cosmos Health, Inc. ?

1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 5.28% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Capital Employed (avg) of 1.92% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared Negative results for the last 3 consecutive quarters
  • NET PROFIT(HY) At USD -6.7 MM has Grown at -89.85%
  • ROCE(HY) Lowest at -104%
  • INTEREST(Q) At USD 1 MM has Grown at 23.38%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -67.80%, its profits have risen by 32.9%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -67.80% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cosmos Health, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Cosmos Health, Inc.
-62.35%
-0.48
92.76%
S&P 500
15.76%
1.22
13.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
5.28%
EBIT Growth (5y)
-251.75%
EBIT to Interest (avg)
-7.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.40%
ROCE (avg)
1.92%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.53
EV to EBIT
-2.33
EV to EBITDA
-2.60
EV to Capital Employed
0.74
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-31.81%
ROE (Latest)
-67.64%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(HY)

At USD 36.91 MM has Grown at 29.71%

NET PROFIT(HY)

Higher at USD -6.7 MM

RAW MATERIAL COST(Y)

Fallen by -14.03% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 14.03 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.59 times

-20What is not working for the Company
NET PROFIT(HY)

At USD -6.7 MM has Grown at -89.85%

ROCE(HY)

Lowest at -104%

INTEREST(Q)

At USD 1 MM has Grown at 23.38%

Here's what is working for Cosmos Health, Inc.

Net Sales
At USD 36.91 MM has Grown at 29.71%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Profit
Higher at USD -6.7 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 14.03 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 3.59 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -14.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cosmos Health, Inc.

Net Profit
At USD -6.7 MM has Grown at -89.85%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest
At USD 1 MM has Grown at 23.38%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Footer loading